Browsing by Author Galván, Patricia
Showing results 1 to 17 of 17
| Issue Date | Title | Author(s) |
|---|---|---|
| 3-Jan-2022 | Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer | Prat Aparicio, Aleix; Guarneri, Valentina; Pascual, Tomás; Brasó Maristany, Fara; Sanfeliu, Esther; Paré Brunet, Laia; Schettini, Francesco; Martínez, Debora; Jares Gerboles, Pedro; Griguolo, Gaia; Dieci, Maria Vittoria; Cortés, Javier; Llombart Cussac, Antonio; Conte, Benedetta; Marín Aguilera, Mercedes; Chic, Núria; Puig Butillé, Joan Anton; Martínez, Antonio; Galván, Patricia; Tsai, Yi-Hsuan; González Farré, Blanca; Mira, Aurea; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Conte, Pierfranco; Perou, Charles M. |
| 7-Nov-2012 | DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis | Mayol Ricart, Gemma; Martín-Subero, José Ignacio; Ríos, José; Queirós, Ana C.; Kulis, Marta; Suñol, Mariona; Esteller, Manel; Gómez, Soledad; Garcia, Idoia; de Torres, Carmen; Rodríguez, Eva; Galván, Patricia; Mora Graupera, Jaume; Lavarino, Cinzia |
| 14-Jul-2020 | ERBB2mRNA expression and response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-positive breast cancer | Griguolo, Gaia; Brasó Maristany, Fara; Gonzalez Farré, Blanca; Pascual, Tomás; Chic, Núria; Saurí, Tamara; Kates, Ronald; Gluz, Oleg; Martínez, Débora; Paré, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz Mateu, Montserrat; Galván, Patricia; Barberá, Laura; Cuatrecasas Freixas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge Escartín, Inés; Villagrasa, Patricia; Soy Muner, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina; Prat Aparicio, Aleix |
| 13-May-2020 | Frequency and spectrum of PIK3CA somatic mutations in breast cancer | Martínez Sáez, Olga; Chic, Núria; Pascual, Tomás; Adamo, Barbara; Vidal Losada, Maria Jesús; Gonzalez-Farre, Xavier; Sanfeliu, Esther; Schettini, Francesco; Conte, Benedetta; Brasó Maristany, Fara; Rodriguez, Adela; Martínez, Debora; Galván, Patricia; Rodríguez, Ana Belén; Martínez, Antonio; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |
| 18-Dec-2013 | Genomic Analyses across Six Cancer Types Identify Basal-like Breast Cancer as a Unique Molecular Entity | Prat Aparicio, Aleix; Adamo, Barbara; Fan, Cheng; Peg, Vicente; Vidal Losada, Maria Jesús; Galván, Patricia; Vivancos, Ana; Nuciforo, Paolo; Palmer, Héctor G.; Dawood, Shaheenah; Rodón, Jordi; Ramón y Cajal Agüeras, Santiago; Campo, Josep Maria; Felip, Enriqueta; Tabernero Caturla, Josep; Cortés, Javier |
| Dec-2022 | HER2DX ERBB2 mRNA expression in advanced HER2- positive breast cancer treated with T-DM1 | Brasó Maristany, Fara; Griguolo, Gaia; Chic, Núria; Pascual, Tomás; Paré Brunet, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez Sáez, Olga; Marín Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz, Montse; Sanfeliu, Esther; González Farré, Blanca; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Conte, Pierfranco; Prat Aparicio, Aleix; Guarneri, Valentina |
| 28-Apr-2023 | HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer | Olivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás |
| 7-Apr-2021 | Identification of cell surface targets for CAR-T cell therapies and antibody-drug conjugates in breast cancer | Schettini, Francesco; Barbao, P; Brasó Maristany, Fara; Galván, Patricia; Martínez, Debora; Paré, Laia; Placido, Sabino De; Prat Aparicio, Aleix; Guedán Carrió, Sònia |
| 19-Mar-2021 | Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer | Griguolo, Gaia; Serna, G.; Pascual, Tomás; Fasani, R.; Guardia, X.; Chic, Núria; Paré, Laia; Pernas, Sònia; Muñoz Mateu, Montserrat; Oliveira, Mafalda; Vidal, M.; Llombart Cussac, Antonio; Cortés, Javier; Galván, Patricia; Bermejo de las Heras, Begoña; Martínez, N.; López, R.; Morales, Serafín; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, E.; Villagrasa, Patricia; Prat Aparicio, Aleix; Nuciforo, Paolo |
| 28-Mar-2017 | Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer | Fernández Martínez, Aranzazu; Pascual, Tomás; Perrone, Giuseppe; Morales, Serafín; Haba, Juan de la; González Rivera, Milagros; Galván, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucía; Prats de Puig, Miquel; Rojo, Federico; Manso, Luis; Paré, Laia; Alonso, Immaculada; Albanell Mestres, Joan; Vivancos, Ana; González, Antonio; Matito, Judit; González, Sonia; Fernández Ruiz, Pedro Luis; Adamo, Barbara; Muñoz Mateu, Montserrat; Viladot, Margarita; Font, Carme; Aya, Francisco; Vidal Losada, Maria Jesús; Caballero, Rosalía; Carrasco, Eva; Altomare, Vittorio; Tonini, Giuseppe; Prat Aparicio, Aleix; Martín, Miguel |
| 18-Sep-2019 | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial | Adamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; Gonzalez Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix |
| 25-Sep-2019 | PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution | Pernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Stradella; Rey, Montse; Garcia Tejedor, Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix |
| 20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
| 30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
| May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |
| 7-Jun-2019 | Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis | Pascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |
| 27-Mar-2014 | The Hippo Transducer TAZ Interacts with the SWI/SNF Complex to Regulate Breast Epithelial Lineage Commitment | Skibinski, Adam; Breindel, Jerrica L.; Prat Aparicio, Aleix; Galván, Patricia; Smith, Elizabeth; Rolfs, Andreas; Gupta, Piyush B.; Labaer, Joshua; Kuperwasser, Charlotte |